[{"address1": "1 Enterprise Drive", "address2": "Suite 430", "city": "Shelton", "state": "CT", "zip": "06484-4779", "country": "United States", "phone": "203 221 7381", "fax": "203 557 3023", "website": "https://www.intensitytherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lewis H. Bender M.A., M.B.A., M.S.", "age": 65, "title": "Founder, President, CEO & Chairman of the Board", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 597007, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Talamo CPA, M.B.A.", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 416930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Wesolowski CPA, M.B.A.", "age": 64, "title": "Principal Accounting Officer & Controller", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 260898, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James M. Ahlers", "age": 60, "title": "Executive Vice President of Corporate Finance", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 75088, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2669, "open": 0.7722, "dayLow": 0.64, "dayHigh": 1.74, "regularMarketPreviousClose": 0.2669, "regularMarketOpen": 0.7722, "regularMarketDayLow": 0.64, "regularMarketDayHigh": 1.74, "payoutRatio": 0.0, "beta": 3.674, "forwardPE": -1.1186441, "volume": 1399761934, "regularMarketVolume": 1399761934, "averageVolume": 26591217, "averageVolume10days": 144511610, "averageDailyVolume10Day": 144511610, "bid": 1.1, "ask": 1.3, "bidSize": 9, "askSize": 9, "marketCap": 64753216, "fiftyTwoWeekLow": 0.185, "fiftyTwoWeekHigh": 3.4, "allTimeHigh": 11.44, "allTimeLow": 0.185, "fiftyDayAverage": 0.2888, "twoHundredDayAverage": 0.966505, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 60025200, "profitMargins": 0.0, "floatShares": 41076219, "sharesOutstanding": 49055462, "sharesShort": 2253998, "sharesShortPriorMonth": 254272, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.045900002, "heldPercentInsiders": 0.12711, "heldPercentInstitutions": 0.06668, "shortRatio": 0.44, "shortPercentOfFloat": 0.048, "impliedSharesOutstanding": 49055462, "bookValue": 0.083, "priceToBook": 15.903616, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -12578000, "trailingEps": -0.82, "forwardEps": -1.18, "52WeekChange": -0.60205007, "SandP52WeekChange": 0.19088471, "quoteType": "EQUITY", "currentPrice": 1.32, "targetHighPrice": 5.0, "targetLowPrice": 1.5, "targetMeanPrice": 2.91667, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 2216000, "totalCashPerShare": 0.047, "totalDebt": 125000, "quickRatio": 1.024, "currentRatio": 1.404, "debtToEquity": 5.723, "returnOnAssets": -1.22675, "returnOnEquity": -3.3412101, "freeCashflow": -6337000, "operatingCashflow": -11085000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "INTS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "PREPRE", "regularMarketChangePercent": 394.567, "regularMarketPrice": 1.32, "corporateActions": [], "postMarketTime": 1761868799, "regularMarketTime": 1761854402, "exchange": "NCM", "messageBoardId": "finmb_225412349", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Intensity Therapeutics, Inc.", "longName": "Intensity Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1688131800000, "postMarketChangePercent": -31.86364, "postMarketPrice": 0.8994, "postMarketChange": -0.42060006, "regularMarketChange": 1.0531, "regularMarketDayRange": "0.64 - 1.74", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 26591217, "fiftyTwoWeekLowChange": 1.135, "fiftyTwoWeekLowChangePercent": 6.135135, "fiftyTwoWeekRange": "0.185 - 3.4", "fiftyTwoWeekHighChange": -2.08, "fiftyTwoWeekHighChangePercent": -0.61176467, "fiftyTwoWeekChangePercent": -60.205006, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.82, "epsForward": -1.18, "epsCurrentYear": -0.365, "priceEpsCurrentYear": -3.6164384, "fiftyDayAverageChange": 1.0312, "fiftyDayAverageChangePercent": 3.5706372, "twoHundredDayAverageChange": 0.35349506, "twoHundredDayAverageChangePercent": 0.36574572, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-06-30", "cryptoTradeable": false, "displayName": "Intensity Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-31"}]